Bayer's Asundexian Drug Reduces Stroke Risk by 26% in Study.

Saved in:
Bibliographic Details
Title: Bayer's Asundexian Drug Reduces Stroke Risk by 26% in Study.
Authors: Wind, Sonja (AUTHOR)
Source: Bloomberg.com. 2/6/2026, pN.PAG-N.PAG. 1p.
Database: Business Source Ultimate
Full text is not displayed to guests.
Description
Description not available.